U.S. tocks closed higher on Monday, continuing last week’s gains. The three major indexes rose for four consecutive days to hit a two-week high. The S&P and Nasdaq both rose by more than 1%, and the S&P recorded its largest four-day winning streak since June
US Markets rose for a fourth consecutive session on rising confidence that high prices may have peaked
EU Markets touched a 2-week high, with banks leading the way, on expectations of more rate hikes
Asia Markets kicked off the week strong, with Japanese travel stocks leading gains on border easing reports
Gold rose more than 1%, trading above $1,720/oz at time of writing on the back of a softer dollar
WTI Crude Oil edged higher, as supply is expected to tighten further this coming December
Twitter retreated almost 2% after a regulatory filing saw it pronouncing Elon Musk’s attempt to back out of the deal invalid
Carvana climbed 7.8% after being upgraded by Piper Sandler from Neutral to Overweight
Gilead Sciences rose more than 4% having revealed the settlement of a patent case regarding its HIV therapies
Alphatec soared 10% following Morgan Stanley’s move to initiate coverage of the company with an overweight rating
- Core & Main (CNM.US)
Economic Calendar (14 September 2022)
- UK Inflation Rate YoY (August)
- US PPI MoM (August)
The information contained in this article has been obtained from public sources which the writer has no reason to believe are unreliable and any analysis, forecast, projections, expectations and opinion (collectively “Research”) contained in this article are based on such information and are expressions of belief only. The writer has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in this presentation is subject to change, and the writer shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will the writer be liable for any loss, including any special, indirect, incidental or consequential damages, which may be incurred from the use of the information or Research made available.
This article is intended for general circulation and educational purposes only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Past performance figures as well as any projection or forecast used in this article, are not necessarily indicative of future performance of any investment products. You should seek advice from a financial adviser regarding the suitability of the investment products mentioned. In the event you choose not to seek advice from a financial adviser, you should consider whether the investment product in question is suitable for you. Views and any strategies described in this article may not be suitable for all investors. Any reference to or discussion of investment products in this article is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products mentioned.